双阴性转移性前列腺癌的基因组和表观基因组景观
Arian Lundberg1,2, Meng Zhang1,2, Rahul Aggarwal1,3
1Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
Cancer research
|June 8, 2023
概括
研究人员在侵袭性前列腺癌亚型中确定了不同的分子驱动因素. 双阴性 (AR-/NE-) 转移性割抵抗性前列腺癌 (mCRPC) 亚型表现出最糟糕的预后,这是由于特定的遗传改变.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 前列腺癌的全身疗法向雄激素信号,但耐药性导致攻击性的亚型.
- 转移性割抵抗性前列腺癌 (mCRPC) 可以发展神经内分泌 (NE) 或双阴性 (AR-/NE-) 特征.
- 攻击性AR-/NE-mCRPC亚型的分子基础仍然不太清楚.
研究的目的:
- 为了全面描述治疗中出现的mCRPC亚型的分子格局.
- 确定双阴性 (AR-/NE-) mCRPC亚型的关键分子驱动因素和独特特征.
- 为了发现攻击性mCRPC的潜在治疗点.
主要方法:
- 从210个mCRPC瘤中对匹配的RNA测序,全基因组测序和全基因组双硫酸盐测序数据的综合分析.
- 对不同的mCRPC亚型进行比较的分子和临床分析,包括AR-/NE-.
- 全基因组甲基化分析以确定调节机制和驱动因素的改变.
主要成果:
- AR-/NE-mCRPC瘤在临床和分子上是不同的,与最短的存活时间有关.
- 在AR-/NE-瘤中发现了染色体重塑剂CHD7和PTEN损失的放大.
- 克鲁佩尔样因子5 (KLF5) 被提名为AR-/NE-表型的驱动因素,与RB1损失有关.
结论:
- AR-/NE-亚型代表了一种具有独特分子驱动因素的高度侵略性的mCRPC形式.
- 了解这些驱动因素,如CHD7和KLF5,对于开发有针对性的疗法至关重要.
- 这项研究提供了关于mCRPC分子异质性的见解,并确定了潜在的治疗途径.
相关概念视频
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K


